Approval · Notice of Compliance 32600 · 2024
ACYCLOVIR SODIUM INJECTION: Notice of Compliance 32600
Issued January 25, 2024
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 32600
- Date
- January 25, 2024
- Company
- Pfizer Canada UlcKirkland, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph. Update to the Package Insert
- Canadian reference product
- ZOVIRAX (Glaxo Wellcome Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| ACYCLOVIR SODIUM INJECTION | Not yet assigned | — |
Medicinal ingredients
- ACYCLOVIR SODIUM 25 MG per ML